↓ Skip to main content

Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7)

Overview of attention for article published in Journal of Translational Medicine, May 2014
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7)
Published in
Journal of Translational Medicine, May 2014
DOI 10.1186/1479-5876-12-s1-o7
Authors

Igor Puzanov, Grant McArthur, Rene Gonzalez, Anna Pavlick, Omid Hamid, Thomas F Gajewski, Ming Yin, Jill Fredrickson, Nicholas Choong, Antoni Ribas

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 33%
Student > Ph. D. Student 1 17%
Student > Master 1 17%
Researcher 1 17%
Professor > Associate Professor 1 17%
Other 0 0%
Readers by discipline Count As %
Medicine and Dentistry 3 50%
Neuroscience 1 17%
Nursing and Health Professions 1 17%
Unknown 1 17%